The small subgroup with positive expression of ER and PgR included females (2/2 =100%), with stage II lung adenocarcinoma at diagnosis (2/2=100%) and subsequently developing lymph-node metastasis (2/2 =100%). Here, ESR1 is linked to metastatic malignant neoplasm in the lymph nodes.